In comparison with HCs, the frequency of plasmablasts (CD19+CD27+CD20-CD38+) was dramatically increased in SLE patients, particularly in active SLE patients, but it was not noticeably different between inactive patients and HCs (Figure 3B). The gene discussed is CD38; the disease is systemic lupus erythematosus.